Immunovant (IMVT) had the highest return between September 7, 2022 and December 7, 2022 by a mid-cap US stock, returning 203.3%.
| ASSET | DATE | % RETURN |
|---|---|---|
Immunovant (IMVT) | 9/7/2022 - 12/7/2022 | 203.32% |
Melco Resorts & Entertainment (MLCO) | 9/7/2022 - 12/7/2022 | 107.58% |
Nuvalent (NUVL) | 9/7/2022 - 12/7/2022 | 106.88% |
Miniso Group Holding (MNSO) | 9/7/2022 - 12/7/2022 | 102.2% |
RLX Technology (RLX) | 9/7/2022 - 12/7/2022 | 96.9% |
Ideaya Biosciences (IDYA) | 9/7/2022 - 12/7/2022 | 92.25% |
F&G Annuities & Life (FG) | 9/7/2022 - 12/7/2022 | 90.5% |
New Gold (NGD) | 9/7/2022 - 12/7/2022 | 75.21% |
Fortuna Silver Mines (FSM) | 9/7/2022 - 12/7/2022 | 74.55% |
Vaxcyte (PCVX) | 9/7/2022 - 12/7/2022 | 68.21% |
ADEIA (ADEA) | 9/7/2022 - 12/7/2022 | 62.93% |
Oceaneering International (OII) | 9/7/2022 - 12/7/2022 | 61.98% |
Intapp (INTA) | 9/7/2022 - 12/7/2022 | 56.43% |
Manchester United (MANU) | 9/7/2022 - 12/7/2022 | 53.15% |
Magnite (MGNI) | 9/7/2022 - 12/7/2022 | 52.84% |
Abercrombie & Fitch (ANF) | 9/7/2022 - 12/7/2022 | 52.67% |
Weatherford International (WFRD) | 9/7/2022 - 12/7/2022 | 52.38% |
Freshpet (FRPT) | 9/7/2022 - 12/7/2022 | 51.9% |
Rambus (RMBS) | 9/7/2022 - 12/7/2022 | 51.03% |
Powell Industries (POWL) | 9/7/2022 - 12/7/2022 | 50.77% |
Halozyme Therapeutics (HALO) | 9/7/2022 - 12/7/2022 | 50.4% |
VEON (VEON) | 9/7/2022 - 12/7/2022 | 50% |
Terns Pharmaceuticals (TERN) | 9/7/2022 - 12/7/2022 | 47.78% |
Eldorado Gold (EGO) | 9/7/2022 - 12/7/2022 | 46.14% |
Atkore International (ATKR) | 9/7/2022 - 12/7/2022 | 45.47% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
